🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with what even is mash? my doc mentioned it and i panicked? Page 3

Has anyone dealt with what even is mash? my doc mentioned it and i panicked?

JessicaH_TX Thu, Sep 18, 2025 at 6:36 AM 21 replies 1,461 viewsPage 3 of 5
fiona_VT
Member
178
890
Dec 2024
Vermont
Sep 18, 2025 at 10:51 AM#11

+1 to PharmacoVig_BOS. Especially the point about "Re: Has anyone dealt with what — the eff..." — I have seen the same in my own experience with Has anyone dealt with.

30 2mark_tokyo, hans_munich, jason_sac26 and 27 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Sep 18, 2025 at 11:08 AM#12

Want to share my personal experience related to Has anyone dealt with what since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 273 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 14 months later: I am down 43 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Has anyone dealt aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

30 23roxy_nash, tony_orlando, Dr.NephBHM_UK and 27 others
Reply Quote Save Share Report
nancy_portland
Member
345
1,567
Aug 2024
Portland, ME
Sep 18, 2025 at 11:25 AM#13

Dr.KarenChen — that is really helpful context on Has anyone dealt with. Follow-up question: did you experience any side effects during this phase?

I am in a similar situation (about to start) and trying to set realistic expectations.

Last edited: Sep 18, 2025 at 12:25 PM
31 13MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 28 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Sep 18, 2025 at 11:42 AM#14

To answer sarah.morrison's question specifically:

From a clinical standpoint, Has anyone dealt with what is something I discuss with patients regularly.

The short answer: discuss this specific situation with your prescribing provider.

The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.

8 5RickReta_CO, PharmHunterJen, TomTeleRx and 5 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Sep 18, 2025 at 11:59 AM#15

Saving this for reference. Quality thread.

39 18mike.trainer_LA, sarah_nash92, FitDadDave and 36 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register